At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 12, 2026 at 09:25 ET
Genmab filed a Form 6-K disclosing a sale of 1,071 shares by Executive Vice President and Chief Commercial Officer Bradley Bailey on November 11, 2026, at an average price of DKK 3,602.98 per share. This is a routine insider transaction disclosure with no material financial impact on the company.
- Bradley Bailey, EVP and Chief Commercial Officer, sold 1,071 shares on November 11, 2026
- Weighted average sale price was DKK 3,602.98 per share
- Transaction took place on NASDAQ Copenhagen
- Total proceeds approximately DKK 3.86 million (about $0.54 million at current exchange rates)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access